申请人:Takeda Chemical Industries, Ltd.
公开号:EP0331505A1
公开(公告)日:1989-09-06
The drug-entrapping liposome composition can be purified advantageously in the practical use by subjecting an aqueous fluid containing drug-entrapping liposomes and the unentrapped drug to dialysis through hollow fibers, thereby separating and removing the unentrapped drug into the fluid flowing outside the hollow fibers.
在实际使用中,药物诱捕脂质体组合物可以通过中空纤维对含有药物诱捕脂质体和未诱捕药物的水性流体进行透析,从而将未诱捕药物分离并移除到流经中空纤维外的流体中,从而有利地纯化药物诱捕脂质体组合物。